1. Home
  2. BFH vs BEAM Comparison

BFH vs BEAM Comparison

Compare BFH & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bread Financial Holdings Inc.

BFH

Bread Financial Holdings Inc.

HOLD

Current Price

$85.52

Market Cap

3.3B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$31.08

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFH
BEAM
Founded
1996
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.0B
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
BFH
BEAM
Price
$85.52
$31.08
Analyst Decision
Hold
Buy
Analyst Count
15
12
Target Price
$80.64
$50.75
AVG Volume (30 Days)
643.6K
2.0M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
1.08%
N/A
EPS Growth
98.36
82.31
EPS
4.15
N/A
Revenue
$4,521,400,000.00
$24,000.00
Revenue This Year
$53.25
N/A
Revenue Next Year
$3.53
$33.77
P/E Ratio
$20.53
N/A
Revenue Growth
N/A
33.33
52 Week Low
$47.87
$15.52
52 Week High
$99.13
$36.44

Technical Indicators

Market Signals
Indicator
BFH
BEAM
Relative Strength Index (RSI) 55.77 59.15
Support Level $68.65 $22.24
Resistance Level $99.13 $32.01
Average True Range (ATR) 3.27 1.81
MACD -0.60 0.01
Stochastic Oscillator 27.88 71.15

Price Performance

Historical Comparison
BFH
BEAM

About BFH Bread Financial Holdings Inc.

Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: